May 15th 2024
Roche's innovative human papillomavirus self-collection solution offers a breakthrough in cervical cancer screening, providing accessible and reliable testing to combat underscreening rates and increase early detection.
Assessing Onclarity HPV assay safety and efficacy for cervical cancer screening
February 21st 2024A recent study evaluated the safety and effectiveness of the Onclarity HPV assay in detecting high-grade cervical disease, presenting findings on its comparability to predicate assays and potential for cost-saving benefits in screening practices.
Read More
Unifying radical hysterectomy classifications with the Querleu-Morrow
February 16th 2024Explore how the latest research underscores the efficacy of the 2017 Querleu-Morrow classification in defining radical hysterectomy extent, shedding light on surgical terminologies for cervical cancer management.
Read More
Protecting HIV-positive adolescents against high-risk HPV types
February 5th 2024A recent study found that the Gardasil quadrivalent HPV vaccine effectively shields HIV-positive adolescents from high-risk HPV types 16, 18, 6, and 11, shedding light on the potential for HPV vaccination to mitigate cancer risks in this vulnerable population.
Read More
FDA clears Genius Digital Diagnostics System for cervical cancer screening
February 2nd 2024Hologic's Genius Digital Diagnostics System, the first FDA-cleared digital cytology system using AI and advanced imaging, promises improved sensitivity in detecting pre-cancerous lesions and cervical cancer cells.
Read More
Two-dose HPV vaccination postpartum shows efficacy
January 30th 2024A recent study revealed a 2-dose regimen of human papillomavirus vaccination in postpartum individuals is as effective as a 3-dose approach, providing valuable insights into optimizing vaccination strategies against the virus.
Read More
Study explores link of social media health videos to HPV awareness
January 18th 2024A recent study found that watching health-related videos on social media significantly increases awareness about human papillomavirus (HPV) and the HPV vaccine, with data showing geographic variations and demographic influences on viewership and awareness levels.
Read More
Long-term HPV vaccine efficacy: 10-year study reveals protection in youth
January 4th 2024A decade-long study confirms significant protection against human papillomavirus remains in patients vaccinated up to age 20, reinforcing the World Health Organization's single-dose vaccination recommendation for adolescents.
Read More
Evaluating efficacy of active surveillance for CIN2
December 13th 2023Discover how active surveillance, a growing approach in managing cervical intraepithelial neoplasia, offers a nuanced alternative to immediate interventions, showcasing promising regression rates and reduced risk of overtreatment.
Read More
A study reveals how personalized digital health tools, such as a Digital Personal Health Librarian, leveraging electronic health records, social data, and advanced technologies, can not only enhance wellness care and preventive health but also significantly improve the uptake of interventions like HPV vaccination.
Read More
Catch-up HPV test offers high predictability for cervical cancer risk in older women
November 16th 2023A recent study suggests that a catch-up HPV test may significantly enhance cervical cancer prediction for women aged 65 and older, potentially addressing issues in existing screening programs and reducing the risk of cervical cancer development.
Read More
Study: African American women with SLE need better education about their HPV, cervical cancer risk
November 7th 2023Authors from a recently published study suggest African American women with systemic lupus erythematosus (SLE) need improved education about their potential risk for cervical cancer and HPV, according to their study results.
Read More
Early HPV vaccination in children
July 13th 2023Jonathan Miller, MD, pediatrician and chief of primary care, pediatrics at Nemours Children’s Health in the Delaware Valley, spoke about the latest data regarding early human papillomavirus (HPV) vaccination in children as young as 9 years old at the 2023 Pediatric Academic Societies meeting. He also provided some clinical pearls for opening the conversation with patients’ caretakers regarding earlier HPV vaccination.
Read More